Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Myricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside
Myricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside
CAS No. 142449-93-2
Myricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside( —— )
Catalog No. M31689 CAS No. 142449-93-2
Myricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside is a natural product for research related to life sciences.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 718 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameMyricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside is a natural product for research related to life sciences.
-
DescriptionMyricetin 3-O-beta-D-xylopyranosyl(1-2)-beta-D-glucopyranoside is a natural product for research related to life sciences.
-
In VitroMyricetin-3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside (30 μM, 14 days) shows inhibitory activity on TG and FFA accumulation in mature 3T3-L1 cells.Myricetin-3-O-β-D-xylopyranosyl-(1→2)-β-D-glucopyranoside (30 μM, 14 days) down-regulates the mRNA expressions of PPARγ, CEBP/α, and ap2.RT-PCRCell Line:3T3-L1 cells Concentration:30 μM Incubation Time:14 days Result:Down-regulated PPARγ, C/EBPα, and ap2 expression.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number142449-93-2
-
Formula Weight612.13
-
Molecular FormulaC26H28O17
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Norswertianolin
Norswertianolin, a compound isolated from G. acuta, functions as a CSE activator and shows promise as a potential cardiovascular therapeutic.
-
LCMV gp33-41 (TFA) (...
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes.
-
anemarsaponin B
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway.
